Skip to main content

Table 4 Substrates, inducers and inhibitors of the cytochrome P450 enzymatic pathways [21, 23]

From: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report

CYP3A4 substrates

Inducers

Inhibitors

Statins (simvastatin, atorvastatin, lovastatin)

Elvitegravir

Hormonal contraceptives

Corticosteroids (budesonide, fluticasone, triamcinolone)

Direct Xa inhibitors (rivaroxaban, apixaban)

Dihydropyridine calcium channel blockers (nifedipine, felodipine)

Antiarrhythmic (amiodarone, propafenone, flecainide)

Benzodiazepines (midazolam, alprazolam, triazolam)

Anti-epileptic drugs (carbamazepine, phenytoin, phenobarbital)

Rifabutin, Rifampin

Dexamethasone

Omeprazole

Non-nucleoside reverse transcriptase inhibitors (efavirenz, nevirapine, etravirine)

Azoles antifungals (fluconazole, itraconazole, ketoconazole)

Macrolides (erythromycin, clarithromycin, azithromycin)

Antidepressants (tricyclic, venlafaxine, fluoxetine, sertraline)

Calcineurin inhibitors (cyclosporine, tacrolimus)

Nondihydropyridine calcium channel blockers (verapamil, diltiazem)

Amiodarone

Protease inhibitors (indinavir, amprenavir, nelfinavir, saquinavir, atazanavir, ritonavir)

Cobicistat

Grapefruit juice